Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders

By Orrin Devinsky, M. Cilio, H. Cross, J. Fernández-Ruiz, J. French, Charlotte L. Hill, R. Katz, V. Di Marzo, Didier Jutras-Aswad, W. Notcutt and 6 more. Epilepsia, 2014

933 citations recorded by the source corpus.

Subfields: Cognitive Neuroscience, Endocrine and Autonomic Systems, Pharmacology

View Paper: https://www.semanticscholar.org/paper/bb1a2486cc1325d0bb8427a43dbcbf898e326aac

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. C. Marmar
2. Travis C. Ruthenburg
3. K. DeCesare
4. J. Manzanares
5. C. Schwartz
6. N. Kane
7. Kristin H. White
8. D. Land

Citations in the corpus

• Cannabidiol as a Potential Treatment for Anxiety Disorders (2015, background): “Preclinical and clinical studies show CBD possesses a wide range of therapeutic properties, including antipsychotic, analgesic, neuroprotective, anticonvulsant, antiemetic, antioxidant, anti-inflammatory, antiarthritic, and antineoplastic properties (see [11, 12, 16–19] for reviews).”
• Genomic and Chemical Diversity in Cannabis (2015, methodology): “cannabidiolic acid (CBDA) plants were historically used in some hashish preparations(32) and are 111 presently in high demand as an anti-seizure therapy (33).”